Zacks Investment Research on MSN

PacBio expands HiFi sequencing reach with new SPRQ-Nx technology

PacBio PACB recently announced the worldwide commercial availability of its SPRQ-Nx sequencing chemistry and new multi-use ...

PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing

New Revio multi-use SMRT Cells reduce sequencing costs by 30% compared to previous SPRQ chemistry while DeepConsensus improvements and expanded methylation calling increase accuracy, yield, and ...
Seeking Alpha

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities

MENLO PARK, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms ...
Labroots

Addressing "NGS Dead Zones" with Third-Generation PacBio Sequencing

SMRT Sequencing is a DNA sequencing technology characterized by long read lengths and high consensus accuracy, regardless of the sequence complexity or GC content of the DNA sample. These ...
Nasdaq

PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop

MENLO PARK, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced the Vega™ system, the company’s first ...